High Court Denies Gilead FCA Case After DOJ Thumbs-Down
The U.S. Supreme Court on Monday chose not to hear a prominent False Claims Act case linking Gilead Sciences Inc. to sketchy drug manufacturing, a move that follows the U.S. Department...To view the full article, register now.
Already a subscriber? Click here to view full article